Prudential Financial
ALDR

Prudential Financial’s Alder Biopharmaceuticals ALDR Stock Holding History

Prudential Financial’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-140,890
Closed -$2.93M – 2400
2017
Q1 		$2.93M Buy
140,890
+22,500
+19% +$498K ﹤0.01% 1372
2016
Q4 		$2.46M Buy
118,390
+25,390
+27% +$660K ﹤0.01% 1439
2016
Q3 		$3.05M Sell
93,000
-3,500
-4% -$107K 0.01% 1304
2016
Q2 		$2.41M Sell
96,500
-7,600
-7% -$206K ﹤0.01% 1474
2016
Q1 		$2.55M Buy
104,100
+11,600
+13% +$269K ﹤0.01% 1440
2015
Q4 		$3.06M Buy
92,500
+22,400
+32% +$757K 0.01% 1308
2015
Q3 		$2.3M Buy
+70,100
New +$2.98M ﹤0.01% 1393

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return